Possible anticancer agents: QSAR analogs of glutamamide: Synthesis and pharmacological activity of 1,5- N, N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides
Based on our earlier QSAR prediction, a series of designed QSAR analogs of 1,5- N, N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides were synthesized as possible anticancer agents. Inhibitions of tumor cell proliferation of the compounds were tested in tumor cell line IMR-32. Anticancer...
Gespeichert in:
Veröffentlicht in: | European journal of medicinal chemistry 2009, Vol.44 (1), p.70-82 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 82 |
---|---|
container_issue | 1 |
container_start_page | 70 |
container_title | European journal of medicinal chemistry |
container_volume | 44 |
creator | Samanta, Soma Alam, Sk. Mahasin Panda, Parthasarathi Jha, Tarun |
description | Based on our earlier QSAR prediction, a series of designed QSAR analogs of 1,5-
N,
N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides were synthesized as possible anticancer agents. Inhibitions of tumor cell proliferation of the compounds were tested in tumor cell line IMR-32. Anticancer activities of these compounds were also evaluated on Swiss Albino mice against Ehrlich Ascites Carcinoma (EAC) cells. Tumor weight inhibition and tumor cell inhibition were considered as anticancer activity parameters. QSAR analysis of these compounds was performed on the basis of a set of descriptors like physicochemical, topological, quantum chemical and DRAGON whole molecular descriptors. The study showed that the increase of length of substituent at R
2 position and the increase of dipole moment of the molecule decrease the anticancer activity of these compounds, presence of bromine atom at R
3 position and hydrophilic substitution at R
2 position are advantageous to the activity. Nucleophilic attack at atom number 14 is advantageous and electrophilic attack at atom number 15 is detrimental to anticancer activity. Atom number 2 is important and may be involved in dispersive interactions of the compounds with enzymes. The results offer an opportunity for further tailoring of these analogs for an active member.
[Display omitted] Based on our earlier QSAR prediction, a series of QSAR analogs of 1,5-
N,
N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides were synthesized, pharmacologically evaluated and QSAR analysis of these compounds was performed. The study showed importance of particular atoms in dispersive interaction of the compounds with the enzymes, as well as the substitution patterns required for improved activity which may offer an opportunity for further tailoring of these analogs for an active member. |
doi_str_mv | 10.1016/j.ejmech.2008.03.008 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66783641</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0223523408001402</els_id><sourcerecordid>66783641</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-1d832c10cd232bb8dfb048c7d95962334d1313c81bd75c695a23922923060a383</originalsourceid><addsrcrecordid>eNp9kctu1DAYhS0EotPCGyDkDQikJvy2EyfpAqmquElVuRTWlmP_mfEol8F2Kk1XvA87HoknwaMZQVesjmx959g6h5AnDHIGTL5a57ge0KxyDlDnIPIk98iCVbLOBC-L-2QBnIus5KI4IschrAGglAAPyRGri1KKii_Iz09TCK7tkeoxOqNHg57qJY4xnNHP1-df0r3up2WgU0eX_Rz1oAdn8Yxeb8e4wuBCIizdrLQftJkSmlJ6qk10Ny5udzZ2Wmb06pRe_f7xK7MuzG2ILs4RbcazF3eOtMXxFkcMc79ZTeO2f3n3yfCIPOh0H_DxQU_It7dvvl68zy4_vvtwcX6ZGdFAzJitBTcMjOWCt21tuxaK2lS2KRvJhSgsE0yYmrW2Ko1sSs1Fw3nDBUjQohYn5Pk-d-On7zOGqAYXDPa9HnGag5KyqoUsWAKLPWh8atFjpzbeDdpvFQO1G0mt1X4ktRtJgVBJku3pIX9uB7T_TIdVEvDsAOiQyux8msWFvxxnUDHJy8S93nOY2rhx6FUwDtOE1nk0UdnJ_f8nfwBkfLRh</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66783641</pqid></control><display><type>article</type><title>Possible anticancer agents: QSAR analogs of glutamamide: Synthesis and pharmacological activity of 1,5- N, N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Samanta, Soma ; Alam, Sk. Mahasin ; Panda, Parthasarathi ; Jha, Tarun</creator><creatorcontrib>Samanta, Soma ; Alam, Sk. Mahasin ; Panda, Parthasarathi ; Jha, Tarun</creatorcontrib><description>Based on our earlier QSAR prediction, a series of designed QSAR analogs of 1,5-
N,
N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides were synthesized as possible anticancer agents. Inhibitions of tumor cell proliferation of the compounds were tested in tumor cell line IMR-32. Anticancer activities of these compounds were also evaluated on Swiss Albino mice against Ehrlich Ascites Carcinoma (EAC) cells. Tumor weight inhibition and tumor cell inhibition were considered as anticancer activity parameters. QSAR analysis of these compounds was performed on the basis of a set of descriptors like physicochemical, topological, quantum chemical and DRAGON whole molecular descriptors. The study showed that the increase of length of substituent at R
2 position and the increase of dipole moment of the molecule decrease the anticancer activity of these compounds, presence of bromine atom at R
3 position and hydrophilic substitution at R
2 position are advantageous to the activity. Nucleophilic attack at atom number 14 is advantageous and electrophilic attack at atom number 15 is detrimental to anticancer activity. Atom number 2 is important and may be involved in dispersive interactions of the compounds with enzymes. The results offer an opportunity for further tailoring of these analogs for an active member.
[Display omitted] Based on our earlier QSAR prediction, a series of QSAR analogs of 1,5-
N,
N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides were synthesized, pharmacologically evaluated and QSAR analysis of these compounds was performed. The study showed importance of particular atoms in dispersive interaction of the compounds with the enzymes, as well as the substitution patterns required for improved activity which may offer an opportunity for further tailoring of these analogs for an active member.</description><identifier>ISSN: 0223-5234</identifier><identifier>EISSN: 1768-3254</identifier><identifier>DOI: 10.1016/j.ejmech.2008.03.008</identifier><identifier>PMID: 18456372</identifier><identifier>CODEN: EJMCA5</identifier><language>eng</language><publisher>Kidlington: Elsevier Masson SAS</publisher><subject>Amides - chemical synthesis ; Amides - pharmacology ; Animals ; Anticancer activity ; Antineoplastic agents ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Biological and medical sciences ; Carcinoma, Ehrlich Tumor - drug therapy ; Carcinoma, Ehrlich Tumor - pathology ; Cell Line, Tumor ; Cell Proliferation - drug effects ; Cluster analysis ; Drug Screening Assays, Antitumor ; EAC ; General aspects ; Glutamamide ; Glutamates - chemical synthesis ; Glutamates - chemistry ; Glutamates - pharmacology ; Humans ; IMR-32 ; Medical sciences ; Mice ; Pharmacology. Drug treatments ; QSAR ; Quantitative Structure-Activity Relationship ; Tumor Burden - drug effects</subject><ispartof>European journal of medicinal chemistry, 2009, Vol.44 (1), p.70-82</ispartof><rights>2008 Elsevier Masson SAS</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-1d832c10cd232bb8dfb048c7d95962334d1313c81bd75c695a23922923060a383</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejmech.2008.03.008$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,4010,27904,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21071625$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18456372$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Samanta, Soma</creatorcontrib><creatorcontrib>Alam, Sk. Mahasin</creatorcontrib><creatorcontrib>Panda, Parthasarathi</creatorcontrib><creatorcontrib>Jha, Tarun</creatorcontrib><title>Possible anticancer agents: QSAR analogs of glutamamide: Synthesis and pharmacological activity of 1,5- N, N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides</title><title>European journal of medicinal chemistry</title><addtitle>Eur J Med Chem</addtitle><description>Based on our earlier QSAR prediction, a series of designed QSAR analogs of 1,5-
N,
N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides were synthesized as possible anticancer agents. Inhibitions of tumor cell proliferation of the compounds were tested in tumor cell line IMR-32. Anticancer activities of these compounds were also evaluated on Swiss Albino mice against Ehrlich Ascites Carcinoma (EAC) cells. Tumor weight inhibition and tumor cell inhibition were considered as anticancer activity parameters. QSAR analysis of these compounds was performed on the basis of a set of descriptors like physicochemical, topological, quantum chemical and DRAGON whole molecular descriptors. The study showed that the increase of length of substituent at R
2 position and the increase of dipole moment of the molecule decrease the anticancer activity of these compounds, presence of bromine atom at R
3 position and hydrophilic substitution at R
2 position are advantageous to the activity. Nucleophilic attack at atom number 14 is advantageous and electrophilic attack at atom number 15 is detrimental to anticancer activity. Atom number 2 is important and may be involved in dispersive interactions of the compounds with enzymes. The results offer an opportunity for further tailoring of these analogs for an active member.
[Display omitted] Based on our earlier QSAR prediction, a series of QSAR analogs of 1,5-
N,
N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides were synthesized, pharmacologically evaluated and QSAR analysis of these compounds was performed. The study showed importance of particular atoms in dispersive interaction of the compounds with the enzymes, as well as the substitution patterns required for improved activity which may offer an opportunity for further tailoring of these analogs for an active member.</description><subject>Amides - chemical synthesis</subject><subject>Amides - pharmacology</subject><subject>Animals</subject><subject>Anticancer activity</subject><subject>Antineoplastic agents</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Ehrlich Tumor - drug therapy</subject><subject>Carcinoma, Ehrlich Tumor - pathology</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation - drug effects</subject><subject>Cluster analysis</subject><subject>Drug Screening Assays, Antitumor</subject><subject>EAC</subject><subject>General aspects</subject><subject>Glutamamide</subject><subject>Glutamates - chemical synthesis</subject><subject>Glutamates - chemistry</subject><subject>Glutamates - pharmacology</subject><subject>Humans</subject><subject>IMR-32</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Pharmacology. Drug treatments</subject><subject>QSAR</subject><subject>Quantitative Structure-Activity Relationship</subject><subject>Tumor Burden - drug effects</subject><issn>0223-5234</issn><issn>1768-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kctu1DAYhS0EotPCGyDkDQikJvy2EyfpAqmquElVuRTWlmP_mfEol8F2Kk1XvA87HoknwaMZQVesjmx959g6h5AnDHIGTL5a57ge0KxyDlDnIPIk98iCVbLOBC-L-2QBnIus5KI4IschrAGglAAPyRGri1KKii_Iz09TCK7tkeoxOqNHg57qJY4xnNHP1-df0r3up2WgU0eX_Rz1oAdn8Yxeb8e4wuBCIizdrLQftJkSmlJ6qk10Ny5udzZ2Wmb06pRe_f7xK7MuzG2ILs4RbcazF3eOtMXxFkcMc79ZTeO2f3n3yfCIPOh0H_DxQU_It7dvvl68zy4_vvtwcX6ZGdFAzJitBTcMjOWCt21tuxaK2lS2KRvJhSgsE0yYmrW2Ko1sSs1Fw3nDBUjQohYn5Pk-d-On7zOGqAYXDPa9HnGag5KyqoUsWAKLPWh8atFjpzbeDdpvFQO1G0mt1X4ktRtJgVBJku3pIX9uB7T_TIdVEvDsAOiQyux8msWFvxxnUDHJy8S93nOY2rhx6FUwDtOE1nk0UdnJ_f8nfwBkfLRh</recordid><startdate>2009</startdate><enddate>2009</enddate><creator>Samanta, Soma</creator><creator>Alam, Sk. Mahasin</creator><creator>Panda, Parthasarathi</creator><creator>Jha, Tarun</creator><general>Elsevier Masson SAS</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2009</creationdate><title>Possible anticancer agents: QSAR analogs of glutamamide: Synthesis and pharmacological activity of 1,5- N, N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides</title><author>Samanta, Soma ; Alam, Sk. Mahasin ; Panda, Parthasarathi ; Jha, Tarun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-1d832c10cd232bb8dfb048c7d95962334d1313c81bd75c695a23922923060a383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Amides - chemical synthesis</topic><topic>Amides - pharmacology</topic><topic>Animals</topic><topic>Anticancer activity</topic><topic>Antineoplastic agents</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Ehrlich Tumor - drug therapy</topic><topic>Carcinoma, Ehrlich Tumor - pathology</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation - drug effects</topic><topic>Cluster analysis</topic><topic>Drug Screening Assays, Antitumor</topic><topic>EAC</topic><topic>General aspects</topic><topic>Glutamamide</topic><topic>Glutamates - chemical synthesis</topic><topic>Glutamates - chemistry</topic><topic>Glutamates - pharmacology</topic><topic>Humans</topic><topic>IMR-32</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Pharmacology. Drug treatments</topic><topic>QSAR</topic><topic>Quantitative Structure-Activity Relationship</topic><topic>Tumor Burden - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Samanta, Soma</creatorcontrib><creatorcontrib>Alam, Sk. Mahasin</creatorcontrib><creatorcontrib>Panda, Parthasarathi</creatorcontrib><creatorcontrib>Jha, Tarun</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Samanta, Soma</au><au>Alam, Sk. Mahasin</au><au>Panda, Parthasarathi</au><au>Jha, Tarun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Possible anticancer agents: QSAR analogs of glutamamide: Synthesis and pharmacological activity of 1,5- N, N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides</atitle><jtitle>European journal of medicinal chemistry</jtitle><addtitle>Eur J Med Chem</addtitle><date>2009</date><risdate>2009</risdate><volume>44</volume><issue>1</issue><spage>70</spage><epage>82</epage><pages>70-82</pages><issn>0223-5234</issn><eissn>1768-3254</eissn><coden>EJMCA5</coden><abstract>Based on our earlier QSAR prediction, a series of designed QSAR analogs of 1,5-
N,
N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides were synthesized as possible anticancer agents. Inhibitions of tumor cell proliferation of the compounds were tested in tumor cell line IMR-32. Anticancer activities of these compounds were also evaluated on Swiss Albino mice against Ehrlich Ascites Carcinoma (EAC) cells. Tumor weight inhibition and tumor cell inhibition were considered as anticancer activity parameters. QSAR analysis of these compounds was performed on the basis of a set of descriptors like physicochemical, topological, quantum chemical and DRAGON whole molecular descriptors. The study showed that the increase of length of substituent at R
2 position and the increase of dipole moment of the molecule decrease the anticancer activity of these compounds, presence of bromine atom at R
3 position and hydrophilic substitution at R
2 position are advantageous to the activity. Nucleophilic attack at atom number 14 is advantageous and electrophilic attack at atom number 15 is detrimental to anticancer activity. Atom number 2 is important and may be involved in dispersive interactions of the compounds with enzymes. The results offer an opportunity for further tailoring of these analogs for an active member.
[Display omitted] Based on our earlier QSAR prediction, a series of QSAR analogs of 1,5-
N,
N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides were synthesized, pharmacologically evaluated and QSAR analysis of these compounds was performed. The study showed importance of particular atoms in dispersive interaction of the compounds with the enzymes, as well as the substitution patterns required for improved activity which may offer an opportunity for further tailoring of these analogs for an active member.</abstract><cop>Kidlington</cop><pub>Elsevier Masson SAS</pub><pmid>18456372</pmid><doi>10.1016/j.ejmech.2008.03.008</doi><tpages>13</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0223-5234 |
ispartof | European journal of medicinal chemistry, 2009, Vol.44 (1), p.70-82 |
issn | 0223-5234 1768-3254 |
language | eng |
recordid | cdi_proquest_miscellaneous_66783641 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Amides - chemical synthesis Amides - pharmacology Animals Anticancer activity Antineoplastic agents Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology Biological and medical sciences Carcinoma, Ehrlich Tumor - drug therapy Carcinoma, Ehrlich Tumor - pathology Cell Line, Tumor Cell Proliferation - drug effects Cluster analysis Drug Screening Assays, Antitumor EAC General aspects Glutamamide Glutamates - chemical synthesis Glutamates - chemistry Glutamates - pharmacology Humans IMR-32 Medical sciences Mice Pharmacology. Drug treatments QSAR Quantitative Structure-Activity Relationship Tumor Burden - drug effects |
title | Possible anticancer agents: QSAR analogs of glutamamide: Synthesis and pharmacological activity of 1,5- N, N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T13%3A20%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Possible%20anticancer%20agents:%20QSAR%20analogs%20of%20glutamamide:%20Synthesis%20and%20pharmacological%20activity%20of%201,5-%20N,%20N%E2%80%B2-disubstituted-2-(substituted%20benzenesulphonyl)%20glutamamides&rft.jtitle=European%20journal%20of%20medicinal%20chemistry&rft.au=Samanta,%20Soma&rft.date=2009&rft.volume=44&rft.issue=1&rft.spage=70&rft.epage=82&rft.pages=70-82&rft.issn=0223-5234&rft.eissn=1768-3254&rft.coden=EJMCA5&rft_id=info:doi/10.1016/j.ejmech.2008.03.008&rft_dat=%3Cproquest_cross%3E66783641%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66783641&rft_id=info:pmid/18456372&rft_els_id=S0223523408001402&rfr_iscdi=true |